| Jeffrey Allen Clark, MD | |
|
1 Medical Center Dr, Lebanon, NH 03756-1000 | |
| (603) 653-0642 | |
| Not Available |
| Full Name | Jeffrey Allen Clark |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 25 Years |
| Location | 1 Medical Center Dr, Lebanon, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609808278 | NPI | - | NPPES |
| 1010560 | Medicaid | VT | |
| 30204314 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 12254 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mary Hitchcock Memorial Hospital | Lebanon, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Amoskeag Anesthesia Pllc | 1759375983 | 93 |
| Dartmouth-hitchcock Clinic | 4183537509 | 1139 |
News Archive
Global life expectancy has risen by more than six years since 1990 as healthy life expectancy grows; ischemic heart disease, lower respiratory infections, and stroke cause the most health loss around the world.
The "little purple lump" appeared in front of Angela Huerta's left ear about six months ago, surprising the 9-year-old girl and worrying her mother. The freckle-sized cyst ached and interfered with her school work.
Neurologix, Inc. today announced that a landmark paper, published on October 20th in Science Translational Medicine demonstrating the importance of the p11 gene in modulating depression in mice, utilized a gene therapy approach to reverse depression in mice for which the Company holds exclusive development rights. Based on the findings reported in the paper, gene therapy may have potential as a new treatment option for people who suffer from severe depression.
A new study co-led by Simon Fraser University health sciences professor Scott Lear provides further evidence of the link between depressive symptoms and an increased risk of heart disease and early death.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that it has received "Fast Track" status from the U.S. Food and Drug Administration for the development of LX1033, an orally-delivered small molecule drug candidate for diarrhea-predominant irritable bowel syndrome (IBS-d).
› Verified 6 days ago
| Entity Name | Amoskeag Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104883511 PECOS PAC ID: 1759375983 Enrollment ID: O20040513001385 |
News Archive
Global life expectancy has risen by more than six years since 1990 as healthy life expectancy grows; ischemic heart disease, lower respiratory infections, and stroke cause the most health loss around the world.
The "little purple lump" appeared in front of Angela Huerta's left ear about six months ago, surprising the 9-year-old girl and worrying her mother. The freckle-sized cyst ached and interfered with her school work.
Neurologix, Inc. today announced that a landmark paper, published on October 20th in Science Translational Medicine demonstrating the importance of the p11 gene in modulating depression in mice, utilized a gene therapy approach to reverse depression in mice for which the Company holds exclusive development rights. Based on the findings reported in the paper, gene therapy may have potential as a new treatment option for people who suffer from severe depression.
A new study co-led by Simon Fraser University health sciences professor Scott Lear provides further evidence of the link between depressive symptoms and an increased risk of heart disease and early death.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that it has received "Fast Track" status from the U.S. Food and Drug Administration for the development of LX1033, an orally-delivered small molecule drug candidate for diarrhea-predominant irritable bowel syndrome (IBS-d).
› Verified 6 days ago
| Entity Name | Dartmouth-hitchcock Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548210198 PECOS PAC ID: 4183537509 Enrollment ID: O20040809000442 |
News Archive
Global life expectancy has risen by more than six years since 1990 as healthy life expectancy grows; ischemic heart disease, lower respiratory infections, and stroke cause the most health loss around the world.
The "little purple lump" appeared in front of Angela Huerta's left ear about six months ago, surprising the 9-year-old girl and worrying her mother. The freckle-sized cyst ached and interfered with her school work.
Neurologix, Inc. today announced that a landmark paper, published on October 20th in Science Translational Medicine demonstrating the importance of the p11 gene in modulating depression in mice, utilized a gene therapy approach to reverse depression in mice for which the Company holds exclusive development rights. Based on the findings reported in the paper, gene therapy may have potential as a new treatment option for people who suffer from severe depression.
A new study co-led by Simon Fraser University health sciences professor Scott Lear provides further evidence of the link between depressive symptoms and an increased risk of heart disease and early death.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that it has received "Fast Track" status from the U.S. Food and Drug Administration for the development of LX1033, an orally-delivered small molecule drug candidate for diarrhea-predominant irritable bowel syndrome (IBS-d).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey Allen Clark, MD 1 Medical Center Dr, Lebanon, NH 03756-1000 Ph: (603) 653-0642 | Jeffrey Allen Clark, MD 1 Medical Center Dr, Lebanon, NH 03756-1000 Ph: (603) 653-0642 |
News Archive
Global life expectancy has risen by more than six years since 1990 as healthy life expectancy grows; ischemic heart disease, lower respiratory infections, and stroke cause the most health loss around the world.
The "little purple lump" appeared in front of Angela Huerta's left ear about six months ago, surprising the 9-year-old girl and worrying her mother. The freckle-sized cyst ached and interfered with her school work.
Neurologix, Inc. today announced that a landmark paper, published on October 20th in Science Translational Medicine demonstrating the importance of the p11 gene in modulating depression in mice, utilized a gene therapy approach to reverse depression in mice for which the Company holds exclusive development rights. Based on the findings reported in the paper, gene therapy may have potential as a new treatment option for people who suffer from severe depression.
A new study co-led by Simon Fraser University health sciences professor Scott Lear provides further evidence of the link between depressive symptoms and an increased risk of heart disease and early death.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that it has received "Fast Track" status from the U.S. Food and Drug Administration for the development of LX1033, an orally-delivered small molecule drug candidate for diarrhea-predominant irritable bowel syndrome (IBS-d).
› Verified 6 days ago
Dr. Matthew James Hoyt, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Dartmouth Hitchcock - Anesthesiology, Lebanon, NH 03756 Phone: 603-650-5922 | |
Marbelia C Gonzalez, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5000 | |
Regina Lee Gritsavage, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Dhmc, Lebanon, NH 03756 Phone: 603-650-5000 | |
Tabitha Antoinette Washington, M.D., B.S. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Dhmc Department Of Anesthesiology, Pain Medicine, Lebanon, NH 03756 Phone: 603-650-6040 Fax: 603-650-8199 | |
Dr. Vinca Wing Kar Chow, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Drive, Dartmouth Hitchcock-anesthesiology & Pain Medicine, Lebanon, NH 03756 Phone: 603-650-6177 | |
Dr. Kimberly Youngren, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5000 | |
Stacie G Deiner, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: One Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5922 |